OneSource Specialty Pharma Approves ESOP Share Allotment
Onesource Specialty Pharma Ltd 路 Others (Uncategorized) 路 27 Oct 2026, 3:48 pm
OneSource Specialty Pharma Approves ESOP Share Allotment OneSource Specialty Pharma Limited approved the allotment of 360 equity shares of face value INR 1 each on 27th Oct'26 under its ESOP 2021 scheme at an exercise price of INR 278 per share (including an INR 277 premium). Following this allotment, the company's paid-up share capital increased from INR 11,46,73,791 (11,46,73,791 shares) to INR 11,46,74,151 comprising 11,46,74,151 equity shares. The newly allotted equity shares rank pari passu with the existing shares.
Original exchange filing (PDF)
More announcements from Onesource Specialty Pharma Ltd
- Intimation of resignation of Senior Management Personnel 路 17 Nov 2026
- Onesource Specialty Pharma Limited has informed the Exchange about the Participation in Jefferies Global Healthcare Conference to be held from November 16, 2026 to November 19, 2026 in London. 路 05 Nov 2026
- Intimation of Transcript of Earnings call dated October 27, 2026 路 03 Nov 2026
- OneSource receives USFDA EIR with VAI Classification, Marking completion of Inspection process at its Sterile Product Division (SPD) Facility in Bengaluru. 路 30 Oct 2026
- Intimation of the Audio recording of the earnings call pertaining to the unaudited financial results for the quarter and half year ended September 30, 2026 路 28 Oct 2026
- OneSource announces strong Q2FY27, results revenue up 37% YoY and EBITDA up 53% YoY 路 27 Oct 2026
- Intimation of change in designation of Dr. Claudio Albrecht from Independent director to Non-Executive Non-Independent Director of the Company. 路 27 Oct 2026
- Onesource Specialty Pharma Limited has submitted to the Exchange, the unaudited financial results (Standalone and Consolidated) for the quarter and half year ended September 30, 2026. 路 27 Oct 2026
